EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Osteochondral Allograft Transplantation for Femoral Head Cartilage Lesions: Minimum 2-Year Follow-Up

Anser Daud, Faran Chaudhry, Doris Braunstein, Oleg A Safir, Allan E Gross, Paul R Kuzyk

The Journal of Arthroplasty · 2024

DOI: 10.1016/j.arth.2024.06.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2024. Verfasst von Anser Daud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Orthopaedic Surgery, Department of Surgery, University…. Hauptthemen laut MEDLINE: Femur Head, Bone Transplantation, Allografts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The surgical management of large osteochondral lesions of the femoral head in young, active patients remains controversial. Fresh osteochondral allograft (OCA) transplantation can be a highly effective treatment for these lesions in some patients. This study investigated survivorship as well as clinical and radiographic outcomes after fresh OCA transplantation at a minimum 2-year follow-up (mean, 6.6 years; range, 0.6 to 13.7 years). METHODS: A retrospective review of 29 patients who underwent plug OCA transplantation for focal femoral head osteochondral lesions between 2008 and 2021 was performed. Patients were assessed clinically using the modified Harris Hip score (mHHS) preoperatively and at each follow-up visit. Postoperative radiographs were evaluated for graft integrity and osteoarthritis severity. Kaplan-Meier survivorship analyses with 95% confidence intervals (CIs) were performed for the endpoint of conversion to total hip arthroplasty (THA). RESULTS: Overall graft survivorship for included patients was 78.4% (95% CI: 62.9 to 93.9) and 62.7% (95% CI: 39.6 to 85.8) at 5 and 10 years, respectively. There were ten patients (34.5%) who underwent conversion to THA. There was a significant difference using the log-rank test between survival for patients who had a preoperative diagnosis of osteonecrosis (ON) versus those who had other diagnoses (P = .002). The ten-year survival for those who had ON was 41.8% (95% CI: 4.8 to 78.8), and the ten-year survival for diagnoses other than ON was 85.7% (95% CI: 59.8 to 100). The mean mHHS score improved significantly (P < .001) from 48.9 (19 to 84) preoperatively to 77.4 (35 to 100) at the final follow-up. There were twenty patients (69.0%) who had mHHS ≥ 70 at the latest follow-up. Arthritic progression, indicated by an increase in the Kellgren and Lawrence grade, occurred in 7 hips (26.9%). CONCLUSIONS: An OCA transplantation is a viable treatment option for osteochondral defects of the femoral head in young, active patients who have minimal preexisting joint deformity. It may delay the progression of arthritis and the need for THA. Patients who had a preoperative diagnosis of ON had worse clinical outcomes than those who had other diagnoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Femur HeadBone TransplantationAllograftsHumansMaleFemaleAdultRetrospective StudiesFollow-Up StudiesTreatment OutcomeMiddle AgedYoung AdultAdolescentCartilage, ArticularTransplantation, HomologousArthroplasty, Replacement, HipGraft Survival

Stichwörter der Autor:innen

cartilage defectcartilage restorationhiposteochondral allografttransplant

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Department of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.

Zitieren

APA

Daud, A., Chaudhry, F., Braunstein, D., Safir, O. A., Gross, A. E., & Kuzyk, P. R. (2024). Outcomes of Osteochondral Allograft Transplantation for Femoral Head Cartilage Lesions: Minimum 2-Year Follow-Up. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.06.030

Vancouver

Daud A, Chaudhry F, Braunstein D, Safir OA, Gross AE, Kuzyk PR. Outcomes of Osteochondral Allograft Transplantation for Femoral Head Cartilage Lesions: Minimum 2-Year Follow-Up. The Journal of Arthroplasty. 2024. doi:10.1016/j.arth.2024.06.030

BibTeX
@article{Daud2024,
  author = {Daud, Anser and Chaudhry, Faran and Braunstein, Doris and Safir, Oleg A and Gross, Allan E and Kuzyk, Paul R},
  title = {Outcomes of Osteochondral Allograft Transplantation for Femoral Head Cartilage Lesions: Minimum 2-Year Follow-Up},
  journal = {The Journal of Arthroplasty},
  year = {2024},
  doi = {10.1016/j.arth.2024.06.030}
}
Kostenlos starten →